Written by DengyuePharma
As cancer treatment enters the era of precision medicine, the emergence of each novel targeted therapy has brought renewed hope to countless patients. CDK4/6 inhibitors, a class of targeted agents focusing on cell cycle regulation, have established a central role in the treatment of hormone receptor–positive (HR+), human epidermal growth factor receptor...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
